Harari PM - Search Results

1

Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites.

Morris ZS, Guy EI, Werner LR, Carlson PM, Heinze CM, Kler JS, Busche SM, Jaquish AA, Sriramaneni RN, Carmichael LL, Loibner H, Gillies SD, Korman AJ, Erbe AK, Hank JA, Rakhmilevich AL, Harari PM, Sondel PM. Morris ZS, et al. Among authors: harari pm. Cancer Immunol Res. 2018 Jul;6(7):825-834. doi: 10.1158/2326-6066.CIR-17-0353. Epub 2018 May 10. Cancer Immunol Res. 2018. PMID: 29748391 Free PMC article.

2

Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck.

Huang SM, Bock JM, Harari PM. Huang SM, et al. Among authors: harari pm. Cancer Res. 1999 Apr 15;59(8):1935-40. Cancer Res. 1999. PMID: 10213503

3

Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas: inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis.

Huang SM, Harari PM. Huang SM, et al. Among authors: harari pm. Clin Cancer Res. 2000 Jun;6(6):2166-74. Clin Cancer Res. 2000. PMID: 10873065

4

Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa).

Huang SM, Li J, Armstrong EA, Harari PM. Huang SM, et al. Among authors: harari pm. Cancer Res. 2002 Aug 1;62(15):4300-6. Cancer Res. 2002. PMID: 12154033

5

Searching for reliable epidermal growth factor receptor response predictors: commentary re M. K. Nyati et al., Radiosensitization by pan-ErbB inhibitor CI-1033 in vitro and in vivo. Clin. Cancer Res., 10: 691-700, 2004.

Harari PM, Huang SM. Harari PM, et al. Clin Cancer Res. 2004 Jan 15;10(2):428-32. doi: 10.1158/1078-0432.ccr-1220-03. Clin Cancer Res. 2004. PMID: 14760061 Review. No abstract available.

6

Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.

Huang S, Armstrong EA, Benavente S, Chinnaiyan P, Harari PM. Huang S, et al. Among authors: harari pm. Cancer Res. 2004 Aug 1;64(15):5355-62. doi: 10.1158/0008-5472.CAN-04-0562. Cancer Res. 2004. PMID: 15289342

7

Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva).

Chinnaiyan P, Huang S, Vallabhaneni G, Armstrong E, Varambally S, Tomlins SA, Chinnaiyan AM, Harari PM. Chinnaiyan P, et al. Among authors: harari pm. Cancer Res. 2005 Apr 15;65(8):3328-35. doi: 10.1158/0008-5472.CAN-04-3547. Cancer Res. 2005. PMID: 15833866

8

Insulin-like growth factor-I receptor signaling blockade combined with radiation.

Allen GW, Saba C, Armstrong EA, Huang SM, Benavente S, Ludwig DL, Hicklin DJ, Harari PM. Allen GW, et al. Among authors: harari pm. Cancer Res. 2007 Feb 1;67(3):1155-62. doi: 10.1158/0008-5472.CAN-06-2000. Cancer Res. 2007. PMID: 17283150 Free article.

9

Augmentation of radiation response by motesanib, a multikinase inhibitor that targets vascular endothelial growth factor receptors.

Kruser TJ, Wheeler DL, Armstrong EA, Iida M, Kozak KR, van der Kogel AJ, Bussink J, Coxon A, Polverino A, Harari PM. Kruser TJ, et al. Among authors: harari pm. Clin Cancer Res. 2010 Jul 15;16(14):3639-47. doi: 10.1158/1078-0432.CCR-09-3385. Epub 2010 May 27. Clin Cancer Res. 2010. PMID: 20507929 Free PMC article.

10

p53 modulates acquired resistance to EGFR inhibitors and radiation.

Huang S, Benavente S, Armstrong EA, Li C, Wheeler DL, Harari PM. Huang S, et al. Among authors: harari pm. Cancer Res. 2011 Nov 15;71(22):7071-9. doi: 10.1158/0008-5472.CAN-11-0128. Epub 2011 Nov 8. Cancer Res. 2011. PMID: 22068033 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

247 results

Search Page